| Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment EB Binder, D Salyakina, P Lichtner, GM Wochnik, M Ising, B Pütz, ... Nature genetics 36 (12), 1319-1325, 2004 | 1086 | 2004 |
| AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011 C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, ... Pharmacopsychiatry 21 (06), 195-235, 2011 | 1057 | 2011 |
| AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011 C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, ... Pharmacopsychiatry 21 (06), 195-235, 2011 | 1057 | 2011 |
| Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017 C Hiemke, N Bergemann, HW Clement, A Conca, J Deckert, K Domschke, ... Pharmacopsychiatry 51 (01/02), 9-62, 2018 | 1052 | 2018 |
| Assessment and management of agitation in psychiatry: expert consensus M Garriga, I Pacchiarotti, S Kasper, SL Zeller, MH Allen, G Vazquez, ... The world journal of biological psychiatry 17 (2), 86-128, 2016 | 312 | 2016 |
| Restless legs syndrome as side effect of second generation antidepressants KG Rottach, BM Schaner, MH Kirch, AZ Zivotofsky, LM Teufel, T Gallwitz, ... Journal of psychiatric research 43 (1), 70-75, 2008 | 288 | 2008 |
| Clinical characteristics and treatment outcome in a representative sample of depressed inpatients–findings from the Munich Antidepressant Response Signature (MARS) project JM Hennings, T Owashi, EB Binder, S Horstmann, A Menke, S Kloiber, ... Journal of psychiatric research 43 (3), 215-229, 2009 | 230 | 2009 |
| Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders R Schennach-Wolff, M Jäger, F Seemüller, M Obermeier, T Messer, ... Schizophrenia research 113 (2-3), 210-217, 2009 | 142 | 2009 |
| Substance abuse in patients with bipolar disorder: A systematic review and meta-analysis T Messer, G Lammers, F Müller-Siecheneder, RF Schmidt, S Latifi Psychiatry research 253, 338-350, 2017 | 126 | 2017 |
| TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians G Schoretsanitis, M Paulzen, S Unterecker, M Schwarz, A Conca, ... The world journal of biological psychiatry 19 (3), 162-174, 2018 | 108 | 2018 |
| Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment G Längle, T Steinert, P Weiser, W Schepp, S Jaeger, C Pfiffner, K Frasch, ... Acta psychiatrica scandinavica 125 (5), 372-381, 2012 | 83 | 2012 |
| Psychopathological characteristics and treatment response of first episode compared with multiple episode schizophrenic disorders M Jäger, M Riedel, T Messer, G Laux, H Pfeiffer, D Naber, LG Schmidt, ... European Archives of Psychiatry and Clinical Neuroscience 257, 47-53, 2007 | 75 | 2007 |
| Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale R SchennachWolff, M Obermeier, F Seemueller, M Jaeger, T Messer, ... Acta Psychiatrica Scandinavica 123 (3), 228-238, 2011 | 69 | 2011 |
| Attitude towards adherence in patients with schizophrenia at discharge R Schennach-Wolff, M Jäger, F Seemüller, M Obermeier, T Messer, ... Journal of psychiatric research 43 (16), 1294-1301, 2009 | 55 | 2009 |
| AGNP-Konsensus-Leitlinien für therapeutisches Drug-Monitoring in der Psychiatrie: Update 2011 C Hiemke, P Baumann, N Bergemann, A Conca, O Dietmaier, K Egberts, ... Psychopharmakotherapie 19 (3), 2012 | 45 | 2012 |
| Equipercentile linking of the Brief Psychiatric Rating Scale and the Clinical Global Impression Scale in a catchment area S Leucht, RR Engel, JM Davis, W Kissling, KM Zur Capellen, M Schmauß, ... European Neuropsychopharmacology 22 (7), 501-505, 2012 | 34 | 2012 |
| Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practice T Messer, M Schmauss, J Lambert-Baumann CNS drugs 19, 43-54, 2005 | 30 | 2005 |
| Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures M Jaeger, T Messer, G Laux, H Pfeiffer, D Naber, LG Schmidt, W Gaebel, ... Pharmacopsychiatry 41 (05), 190-195, 2008 | 27 | 2008 |
| Mobility behaviour and driving status of patients with mental disorders–an exploratory study A Brunnauer, V Buschert, F Segmiller, S Zwick, J Bufler, M Schmauss, ... International journal of psychiatry in clinical practice 20 (1), 40-46, 2016 | 26 | 2016 |
| Time course of antipsychotic treatment response in schizophrenia: results from a naturalistic study in 280 patients M Jaeger, M Riedel, M Obermeier, R Schennach-Wolff, F Seemueller, ... Schizophrenia research 118 (1-3), 183-188, 2010 | 25 | 2010 |
